132 related articles for article (PubMed ID: 17310291)
1. Heterogeneous delayed enhancement of hepatic parenchyma after intravenous infusion of sonographic contrast agent: a new hypothesis.
Caruso G; Martegani A; Aiani L; Borghi C; Verderame F; Campisi A; Salvaggio G; Lagalla R; Cardinale AE
Radiol Med; 2007 Feb; 112(1):56-63. PubMed ID: 17310291
[TBL] [Abstract][Full Text] [Related]
2. Bolus versus continuous infusion of microbubble contrast agent for liver ultrasound by using an automatic power injector in humans: A pilot study.
Quaia E; Gennari AG; Angileri R; Cova MA
J Clin Ultrasound; 2016; 44(3):136-42. PubMed ID: 26302446
[TBL] [Abstract][Full Text] [Related]
3. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
[TBL] [Abstract][Full Text] [Related]
4. Grey-scale contrast enhancement in rabbit liver with SonoVue at different doses.
Li J; Dong B; Yu X; Wang X; Li C
Ultrasound Med Biol; 2005 Feb; 31(2):185-90. PubMed ID: 15708457
[TBL] [Abstract][Full Text] [Related]
5. [Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions].
Strunk H; Börner N; Stuckmann G; Fröhlich E; Hadizadeh D
Rofo; 2005 Oct; 177(10):1394-404. PubMed ID: 16170709
[TBL] [Abstract][Full Text] [Related]
6. Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US.
Bartolotta TV; Taibbi A; Galia M; Lo Re G; La Grutta L; Grassi R; Midiri M
Eur J Radiol; 2007 Dec; 64(3):447-55. PubMed ID: 17433596
[TBL] [Abstract][Full Text] [Related]
7. Definition of contrast enhancement phases of the liver using a perfluoro-based microbubble agent, perflubutane microbubbles.
Shunichi S; Hiroko I; Fuminori M; Waki H
Ultrasound Med Biol; 2009 Nov; 35(11):1819-27. PubMed ID: 19713032
[TBL] [Abstract][Full Text] [Related]
8. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
9. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
[TBL] [Abstract][Full Text] [Related]
10. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
11. Multi-detector row helical CT of the liver: quantitative assessment of iodine concentration of intravenous contrast material on multiphasic CT--a prospective randomized study.
Tsurusaki M; Sugimoto K; Fujii M; Sugimura K
Radiat Med; 2004; 22(4):239-45. PubMed ID: 15468944
[TBL] [Abstract][Full Text] [Related]
12. MDCT of the pancreas: optimizing scanning delay with a bolus-tracking technique for pancreatic, peripancreatic vascular, and hepatic contrast enhancement.
Kondo H; Kanematsu M; Goshima S; Miyoshi T; Shiratori Y; Onozuka M; Moriyama N; Bae KT
AJR Am J Roentgenol; 2007 Mar; 188(3):751-6. PubMed ID: 17312064
[TBL] [Abstract][Full Text] [Related]
13. Macro- and microcirculation patterns of intrahepatic blood flow changes in patients with hereditary hemorrhagic telangiectasia.
Schelker RC; Barreiros AP; Hart C; Herr W; Jung EM
World J Gastroenterol; 2017 Jan; 23(3):486-495. PubMed ID: 28210085
[TBL] [Abstract][Full Text] [Related]
14. Delayed contrast enhancement of hepatic parenchyma after intravenous sonographic contrast agent: unusual phenomenon. Case report and review of literature.
Tarnoki DL; Tarnoki AD; Sukosd H; Folhoffer A; Harkanyi Z
J Ultrasound; 2021 Mar; 24(1):3-9. PubMed ID: 31981154
[TBL] [Abstract][Full Text] [Related]
15. Safety of Sulfur Hexafluoride Microbubbles in Sonography of Abdominal and Superficial Organs: Retrospective Analysis of 30,222 Cases.
Tang C; Fang K; Guo Y; Li R; Fan X; Chen P; Chen Z; Liu Q; Zou Y
J Ultrasound Med; 2017 Mar; 36(3):531-538. PubMed ID: 28072475
[TBL] [Abstract][Full Text] [Related]
16. Effects of injection rates of contrast material on arterial phase hepatic CT.
Kim T; Murakami T; Takahashi S; Tsuda K; Tomoda K; Narumi Y; Oi H; Nakamura H
AJR Am J Roentgenol; 1998 Aug; 171(2):429-32. PubMed ID: 9694469
[TBL] [Abstract][Full Text] [Related]
17. Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound.
Gauthier TP; Wasan HS; Muhammad A; Owen DR; Leen EL
J Ultrasound Med; 2011 Mar; 30(3):379-85. PubMed ID: 21357560
[TBL] [Abstract][Full Text] [Related]
18. Persistent Heterogeneous Liver Enhancement after US Contrast Material Injection.
Vij A; Fetzer DT
Radiology; 2019 Sep; 292(3):539. PubMed ID: 31335260
[No Abstract] [Full Text] [Related]
19. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
20. Hepatic perfusion parameters of contrast-enhanced ultrasonography correlate with the severity of chronic liver disease.
Liu D; Qian L; Wang J; Hu X; Qiu L
Ultrasound Med Biol; 2014 Nov; 40(11):2556-63. PubMed ID: 25218453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
